title: Serum Zta antibody of Epstein-Barr virus exerts potential function in the diagnosis of nasopharyngeal cancer.
abstract: The diagnosis of nasopharyngeal cancer (NPC) remains a clinical challenge. Many studies have assessed the diagnostic potential of Zta antibody of the Epstein-Barr virus (EBV) in NPC patients but with controversial results. This study aims to summarize the overall diagnostic performance of EBV Zta antibody in NPC. Based on a comprehensive search of the Pubmed and Embase, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Wanfang Databases and China Citation Databases, we identified outcome data from all articles estimating diagnostic accuracy of EBV Zta antibody for NPC. A summary estimation for sensitivity, specificity, and other diagnostic indexes were pooled using a bivariate model. The overall measure of accuracy was calculated using summary receiver operating characteristic curve and the area under curve (AUC) was calculated. According to our inclusion criteria, 17 studies with 11,822 subjects (1,645 NPC cases, 10,177 controls) were included. The summary estimates were: sensitivity 0.87 (95 % confidence interval [CI] = 0.86-0.89), specificity 0.94 (95 % CI = 0.93-0.94), positive likelihood ratio 8.05 (95 % CI = 5.59-11.59), negative likelihood ratio 0.16 (95 % CI = 0.12-0.21), diagnostic odds ratio 52.93 (95 % CI = 29.95-93.56), the AUC and Q* index were 0.9352 and 0.8714, respectively. In conclusion, serum EBV Zta had a better diagnostic performance for NPC. Further studies should be performed to confirm our findings.
authors.affiliation: Department of Medicine Oncology, Linyi City People's Hospital, Linyi, 276000, China.
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Zhang
authors.forename: Yun
authors.initials: Y
authors.lastname: Zhang
authors.forename: Yunqiang
authors.initials: Y
authors.lastname: Nie
authors.forename: Shoufeng
authors.initials: S
authors.lastname: Wang
authors.forename: Yanlin
authors.initials: Y
authors.lastname: Chen
authors.forename: Dezhong
authors.initials: D
authors.lastname: Sun
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000473:pathology; D015534:Trans-Activators / Q000097:blood / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; C063676:BZLF1 protein, Herpesvirus 4, Human; D015534:Trans-Activators
references.citation: AJR Am J Roentgenol. 2006 Aug;187(2):271-81
references.pmid: 16861527
references.citation: BMC Med Res Methodol. 2006 Jul 12;6:31
references.pmid: 16836745
references.citation: Int J Cancer. 1991 Jul 9;48(5):647-9
references.pmid: 1649137
references.citation: BMC Med Res Methodol. 2011 Apr 07;11:41
references.pmid: 21473747
references.citation: Cancer Immunol Immunother. 1995 Apr;40(4):251-6
references.pmid: 7750123
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1765-77
references.pmid: 17035381
references.citation: J Clin Epidemiol. 2001 Oct;54(10):1046-55
references.pmid: 11576817
references.citation: Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Sep;20(3):263-5
references.pmid: 17086289
references.citation: BMJ. 1997 Oct 18;315(7114):980-8
references.pmid: 9365295
references.citation: Int J Cancer. 1976 Jan 15;17(1):1-7
references.pmid: 175020
references.citation: Cancer. 1994 Nov 1;74(9):2414-24
references.pmid: 7922994
references.citation: J Gen Virol. 2008 Nov;89(Pt 11):2833-2842
references.pmid: 18931081
references.citation: BMJ. 2009 Jul 21;339:b2700
references.pmid: 19622552
references.citation: Ann Intern Med. 2008 Dec 16;149(12):889-97
references.pmid: 19075208
references.citation: Ai Zheng. 2009 Feb;28(2):177-80
references.pmid: 19550133
references.citation: Int J Cancer. 2003 Jul 10;105(5):706-9
references.pmid: 12740922
references.citation: Proc Natl Acad Sci U S A. 1966 Dec;56(6):1699-704
references.pmid: 16591407
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Ai Zheng. 2003 Sep;22(9):903-6
references.pmid: 12969518
references.citation: J Clin Epidemiol. 2003 Nov;56(11):1129-35
references.pmid: 14615004
references.citation: Eur Radiol. 2010 Jan;20(1):16-24
references.pmid: 19657655
references.citation: Int J Cancer. 2000 Apr 1;86(1):71-5
references.pmid: 10728597
references.citation: BMJ. 2003 Sep 6;327(7414):557-60
references.pmid: 12958120